Diagnostic Pathology Services
Customize your policy alerts
Sign up for Highmark Delaware Policy RP-074 alerts
Get alerted when Policy RP-074 changes without checking for updates manually.
Monitor payer policy activity
This policy governs reimbursement for covered diagnostic pathology services that lack pricing on the Medicare Clinical Laboratory Fee Schedule. It applies to providers submitting applicable professional claims in specified commercial and Medicare Advantage markets.
The policy was end dated retroactively.
Diagnostic Pathology Reimbursement Criteria
Services without Medicare fee-schedule pricing
For dates of service January 1, 2022, and thereafter, the Plan reimburses diagnostic pathology services without pricing on the Medicare Clinical Laboratory Fee Schedule as follows:
ALL of the following
ALL of the following
- Service is a diagnostic pathology service.
- The service does not have pricing on the Medicare Clinical Laboratory Fee Schedule.
- Reimburse at 70% of the first appearance on a Medicare Clinical Laboratory Fee Schedule or a carrier's fee schedule.
Covered services without a published Medicare fee
For dates of service January 1, 2022, and thereafter, covered diagnostic pathology services without a published Medicare Clinical Laboratory Fee Schedule fee are reimbursed as follows:
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.